Technical Analysis for BCT - Briacell Therapeutics Corp.

Grade Last Price % Change Price Change
F 2.860 -3.05% -0.090
BCT closed down 3.05 percent on Friday, April 19, 2024, on 54 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New Downtrend Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Briacell Therapeutics Corp. Description

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company. The Company is engaged in the research and development of cancer immunotherapy technology. The Company offers BriaVax, an immunotherapy vaccine. The Company is engaged in developing and advancing its BriaVax immunotherapy vaccine for patients with advanced breast cancer. The Company is also engaged in the research and development of its companion diagnostic product, BriaDx. The Company's BriaDx program is focused on analyzing samples obtained from patients previously treated with BriaVax along with co-analysis of previously manufactured vaccine lots. The Company's analysis methods include various technologies, including gene expression profiling by Illumina microarrays and human leukocyte antigen (HLA) typing by a high-resolution method. The Company is focused on understanding the mechanism of action (MoA) of BriaVax.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Medical Specialties Therapy Oncology Immunology Antigen Immunotherapy Cancer Immunotherapy Biotechnology Companies Breast Cancer Vaccine

Is BCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.29
52 Week Low 2.86
Average Volume 10,321
200-Day Moving Average 6.502
50-Day Moving Average 4.031
20-Day Moving Average 3.555
10-Day Moving Average 3.379
Average True Range 0.249
RSI (14) 31.03
ADX 25.29
+DI 15.417
-DI 39.017
Chandelier Exit (Long, 3 ATRs) 3.332
Chandelier Exit (Short, 3 ATRs) 3.608
Upper Bollinger Bands 4.244
Lower Bollinger Band 2.865
Percent B (%b) 0.0
BandWidth 38.802
MACD Line -0.293
MACD Signal Line -0.234
MACD Histogram -0.059
Fundamentals Value
Market Cap 2.21 Million
Num Shares 772 Thousand
EPS -0.04
Price-to-Earnings (P/E) Ratio -75.26
Price-to-Sales 0.00
Price-to-Book 10.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.190
Resistance 3 (R3) 3.227 3.153 3.135
Resistance 2 (R2) 3.153 3.069 3.135 3.117
Resistance 1 (R1) 3.007 3.017 2.970 2.970 3.098
Pivot Point 2.933 2.933 2.915 2.915 2.933
Support 1 (S1) 2.787 2.849 2.750 2.750 2.622
Support 2 (S2) 2.713 2.797 2.695 2.603
Support 3 (S3) 2.567 2.713 2.585
Support 4 (S4) 2.530